Olema Pharmaceuticals inc (OLMA)
12.19
-0.03
(-0.25%)
USD |
NASDAQ |
Sep 27, 16:00
12.19
0.00 (0.00%)
After-Hours: 20:00
Olema Pharmaceuticals Free Cash Flow: -92.43M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -92.43M |
| March 31, 2024 | -86.98M |
| December 31, 2023 | -83.73M |
| September 30, 2023 | -85.14M |
| June 30, 2023 | -80.52M |
| March 31, 2023 | -84.89M |
| December 31, 2022 | -82.43M |
| September 30, 2022 | -81.85M |
| Date | Value |
|---|---|
| June 30, 2022 | -75.91M |
| March 31, 2022 | -58.69M |
| December 31, 2021 | -52.26M |
| September 30, 2021 | -42.03M |
| June 30, 2021 | -37.36M |
| March 31, 2021 | -29.28M |
| December 31, 2020 | -19.92M |
Free Cash Flow Range, Past 5 Years
-92.43M
Minimum
Jun 2024
-19.92M
Maximum
Dec 2020
-66.23M
Average
-80.52M
Median
Jun 2023
Free Cash Flow Benchmarks
| NovaBay Pharmaceuticals Inc | -3.396M |
| Palatin Technologies Inc | -33.83M |
| iBio Inc | -18.55M |
| Theriva Biologics Inc | -18.01M |
| Oragenics Inc | -7.214M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -27.56M |
| Cash from Investing (Quarterly) | -4.878M |
| Cash from Financing (Quarterly) | 15.60M |
| Free Cash Flow Per Share (Quarterly) | -0.4897 |
| Free Cash Flow Yield | -14.32% |